Upgrade to SI Premium - Free Trial

uniQure (QURE)

27.00 +0.55 (2.08%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/4/26)

Latest Headlines

Form 4 uniQure N.V. For: Jun 03 Filed by: Kaye Jack June 5, 2026 4:43 PM - SEC Filing Form 144 uniQure N.V. Filed by: Kaye Jack June 3, 2026 3:58 PM - SEC Filing Form SCHEDULE 13G/A uniQure N.V. Filed by: RTW INVESTMENTS, LP May 15, 2026 8:40 AM - SEC Filing Form 4 uniQure N.V. For: May 08 Filed by: Abi-Saab Walid May 12, 2026 4:55 PM - SEC Filing FDA Commissioner Marty Makary is resigning - Politico reporter on X May 12, 2026 12:49 PM - StreetInsider Form SCHEDULE 13G uniQure N.V. Filed by: STATE STREET CORP May 12, 2026 12:14 PM - SEC Filing Form 144 uniQure N.V. Filed by: Abi-Saab Walid May 8, 2026 4:01 PM - SEC Filing uniQure BV (QURE) PT Lowered to $50 at H.C. Wainwright May 7, 2026 7:44 AM - StreetInsider Form SCHEDULE 13G/A uniQure N.V. Filed by: FMR LLC May 6, 2026 11:41 AM - SEC Filing uniQure BV (QURE) PT Raised to $14 at Goldman Sachs May 6, 2026 6:44 AM - StreetInsider uniQure (QURE) Tops Q1 EPS by 2c May 5, 2026 7:28 AM - StreetInsider Form 10-Q uniQure N.V. For: Mar 31 May 5, 2026 7:16 AM - SEC Filing Form 8-K uniQure N.V. For: May 05 May 5, 2026 7:07 AM - SEC Filing uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates May 5, 2026 7:05 AM - Globe NewsWire Form SCHEDULE 13G/A uniQure N.V. Filed by: Aberdeen Group plc April 30, 2026 10:20 AM - SEC Filing Form 8-K uniQure N.V. For: Apr 30 April 30, 2026 7:07 AM - SEC Filing uniQure plans UK regulatory filing for Huntington's disease gene therapy April 30, 2026 7:06 AM - StreetInsider uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease April 30, 2026 7:05 AM - Globe NewsWire uniQure to Announce First Quarter 2026 Financial Results April 28, 2026 7:05 AM - Globe NewsWire Form ARS uniQure N.V. For: Dec 31 April 27, 2026 7:03 AM - SEC Filing Form DEFA14A uniQure N.V. April 27, 2026 7:01 AM - SEC Filing Form DEF 14A uniQure N.V. For: Jun 10 April 27, 2026 7:00 AM - SEC Filing uniQure BV (QURE) PT Raised to $10 at Goldman Sachs April 20, 2026 6:51 AM - StreetInsider Form PRE 14A uniQure N.V. For: Jun 10 April 16, 2026 5:01 PM - SEC Filing uniQure BV (QURE) PT Lowered to $25 at Barclays March 23, 2026 2:36 AM - StreetInsider uniQure faces securities fraud lawsuit over FDA approval delay March 17, 2026 10:39 PM - StreetInsider uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC March 17, 2026 10:39 PM - Globe NewsWire QURE Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in uniQure N.V. Securities Lawsuit -- The Gross Law Firm March 17, 2026 9:02 AM - PR NewsWire Portnoy Law Firm Announces Class Action on Behalf of uniQure N.V. Investors March 16, 2026 11:19 AM - Globe NewsWire Law firm announces class action lawsuit against uniQure over FDA delay March 13, 2026 9:57 PM - StreetInsider uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC March 13, 2026 9:57 PM - PR NewsWire QURE Shareholder Alert: April 13, 2026 Lead Plaintiff Deadline in uniQure N.V. Securities Class Action Lawsuit — The Gross Law Firm March 13, 2026 9:00 AM - Globe NewsWire uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE March 11, 2026 9:55 PM - Globe NewsWire uniQure faces securities fraud lawsuit after FDA approval delay March 10, 2026 10:17 PM - StreetInsider uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC March 10, 2026 10:17 PM - Globe NewsWire Mizuho Upgrades uniQure BV (QURE) to Outperform, Raise PT to $35 March 10, 2026 4:21 PM - StreetInsider uniQure N.V. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 13, 2026 to Discuss Your Rights - QURE March 10, 2026 9:01 AM - PR NewsWire Full Article List